Clinical trials
Phase 2 trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,438 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 13 |
| 2004 | 25 |
| 2005 | 29 |
| 2006 | 55 |
| 2007 | 57 |
| 2008 | 99 |
| 2009 | 101 |
| 2010 | 118 |
| 2011 | 121 |
| 2012 | 123 |
| 2013 | 96 |
| 2014 | 100 |
| 2015 | 133 |
| 2016 | 112 |
| 2017 | 118 |
| 2018 | 131 |
| 2019 | 129 |
| 2020 | 146 |
| 2021 | 161 |
| 2022 | 129 |
| 2023 | 132 |
| 2024 | 115 |
| 2025 | 116 |
| 2026 | 71 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,256 |
| Unknown status | 403 |
| Terminated | 281 |
| Recruiting | 242 |
| Active, not recruiting | 198 |
| Withdrawn | 29 |
| Not yet recruiting | 19 |
| Enrolling by invitation | 8 |
| Suspended | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Samsung Medical Center | 169 |
| Seoul National University Hospital | 144 |
| Yonsei University | 123 |
| Asan Medical Center | 116 |
| Novartis Pharmaceuticals | 97 |
| National Cancer Center, Korea | 84 |
| Pfizer | 78 |
| AstraZeneca | 69 |
| GlaxoSmithKline | 64 |
| Merck Sharp & Dohme LLC | 52 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 191 |
| Breast Neoplasms | 106 |
| Stomach Neoplasms | 103 |
| Carcinoma, Hepatocellular | 74 |
| Neoplasms | 74 |
| Neoplasm Metastasis | 68 |
| Lung Neoplasms | 60 |
| Recurrence | 56 |
| Colorectal Neoplasms | 55 |
| Pancreatic Neoplasms | 46 |
Trials
Showing 1 to 25 of 2,438. Each trial links to its page on Pharma Observatory.
2,338 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.